Skip to content
10-Q

Quarterly Report

IVERIC bio, Inc.

0001410939-23-000064

← back to feed
Filed
May 10, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 1, 2023 137.78M sh
Shares Diluted Q1 2023 · Mar 31, 2023 137.09M sh
Shares Diluted Q1 2023 · Mar 31, 2022 118.76M sh
Capex Q1 2023 · Mar 31, 2023 $233K
Capex Q1 2023 · Mar 31, 2022 $116K
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$50.59M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$37.51M
Long Term Debt Q1 2023 · Mar 31, 2023 $96.99M
Long Term Debt Q1 2023 · Dec 31, 2022 $96.57M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $467.57M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $476.3M
Stockholders Equity Q1 2023 · Mar 31, 2023 $477.05M
Stockholders Equity Q1 2023 · Dec 31, 2022 $534.66M
Stockholders Equity Q1 2023 · Mar 31, 2022 $333.15M
Stockholders Equity Q1 2023 · Dec 31, 2021 $360.53M
Current Liabilities Q1 2023 · Mar 31, 2023 $39.37M
Current Liabilities Q1 2023 · Dec 31, 2022 $35.59M
Total Liabilities Q1 2023 · Mar 31, 2023 $136.36M
Total Liabilities Q1 2023 · Dec 31, 2022 $132.17M
Current Assets Q1 2023 · Mar 31, 2023 $611.54M
Current Assets Q1 2023 · Dec 31, 2022 $662.83M
Total Assets Q1 2023 · Mar 31, 2023 $613.41M
Total Assets Q1 2023 · Dec 31, 2022 $666.82M
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.53
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.29
Eps Basic Q1 2023 · Mar 31, 2023 −$0.53
Eps Basic Q1 2023 · Mar 31, 2022 −$0.29
Sga Expense Q1 2023 · Mar 31, 2023 $31.76M
Sga Expense Q1 2023 · Mar 31, 2022 $12.11M
Rd Expense Q1 2023 · Mar 31, 2023 $42.08M
Rd Expense Q1 2023 · Mar 31, 2022 $22.56M
Net Income Q1 2023 · Mar 31, 2023 −$72.23M
Net Income Q1 2023 · Mar 31, 2022 −$34.54M
Operating Income Q1 2023 · Mar 31, 2023 −$73.84M
Operating Income Q1 2023 · Mar 31, 2022 −$34.67M